SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 32 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 46,902,000 | $45,737,000 | 4.40% |
| INCOME RESEARCH & MANAGEMENT | 7,500,000 | $7,280,000 | 3.12% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 96,994,000 | $94,477,000 | 2.13% |
| PIPER SANDLER & CO. | 2,200,000 | $2,112,000 | 1.92% |
| DeepCurrents Investment Group LLC | 41,092,000 | $39,934,000 | 1.59% |
| Radcliffe Capital Management, L.P. | 69,010,000 | $66,983,000 | 1.54% |
| Sonora Investment Management Group, LLC | 9,635,000 | $9,389,000 | 0.89% |
| Penn Mutual Asset Management | 675,000 | $656,000 | 0.88% |
| OAKTREE CAPITAL MANAGEMENT LP | 24,447,000 | $23,851,000 | 0.28% |
| WOLVERINE ASSET MANAGEMENT LLC | 8,681,000 | $8,429,000 | 0.08% |